Naim Farhat, MD

Naim Farhat, MD



236 Ratings 5 Reviews


Cardiology-Interventional Cardiology, Cardiology

Accepting New Patients

Primary Location

North Ohio Heart, Inc
125 E Broad St
Elyria, OH 44035

View All (2)

Schedule an Appointment


Are you pregnant or have you had a baby in the last 2 months?


  • Assistant Clinical Professor
  • Director, Harrington Heart and Vascular Institute


  • Cardiology
  • Interventional Cardiology


Watch to find out more about this University Hospitals physician.

Office Locations

North Ohio Heart, Inc

125 E Broad St
Elyria OH, 44035

Get Directions

North Ohio Heart Inc/Ohio Medical Group

29325 Health Campus Dr
Westlake OH, 44145

Get Directions

Patient Satisfaction Reviews

4.8 out of 5

236 Ratings

Patient Comments (5)

Reviewed On 1/2/2019
Dr. Farhat always goes through all of my tests with me and explains things in details that I can understand.

Reviewed On 12/15/2018
Dr. Farhat is a good communicatior, staff is always attentive and polite. And the Dr knows is way around the cath lab.

Reviewed On 12/10/2018
I"am very happy with Dr. Farhat and North Ohio Heart.

Reviewed On 11/26/2018
very happy with my doctor- Dr Farhat.

Reviewed On 11/3/2018
Dr Farhat was excellent.This was my 1st. visit. My former cardiologist retired in ****.I was very pleased with this physician & plan to remain a patient.

Board Certifications

  • Interventional Cardiology - American Board of Internal Medicine
  • Cardiovascular Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


Residency | Cardiovascular Disease
Cardiovascular Disease - Metrohealth Medical Center (1986 - 1988)

Residency | Internal Medicine
Internal Medicine - Metrohealth Medical Center (1983 - 1986)

Residency | Anatomic and Clinical Pathology
Anatomic and Clinical Pathology - Metrohealth Medical Center (1982 - 1983)

Medical Education
University Of Damascus Faculty Of Medicine (1980)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Naim Farhat did not disclose any Outside Relationships with Industry.

Back to Top